Cleerly

Series-B+
cleerly.com Biotech & Healthcare Denver, United States Founded 2019 101-250
Total Funding $106M
Latest Round Undisclosed Series-B+
Last Announced Jan 24, 2025
Investors 15 Backers
Decision Makers 2 Verified

About Cleerly

Cleerly provides an AI-driven platform that quantifies and assesses coronary artery disease (CAD) to deliver clinically actionable insights through a web-based solution. Its software analyzes and characterizes plaque, calculates stenosis, and detects likely ischemia in specific vessels. Cleerly's customers include healthcare providers, payors, and patients. The company offers its solutions through software demonstrations and aims to empower personalized treatment decisions.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Denver, United States
Year Founded 2019
Team Size 101-250
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website cleerly.com
Domain Registered Date May 12, 2011

Social & Network Presence

X / Twitter Profile @Cleerlyhealth (3.0K followers) Created on Aug 2021
LinkedIn Corporate Not linked

Company Milestones & Timeline

6 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  2. Capital Raise

    Raised $106,000,000 · Series-B+

    fundraisingfox.com

  3. Capital Raise

    Series-B+ announced

  4. Milestone

    X account created (@Cleerlyhealth)

    3.0K followers

  5. Milestone

    Company founded

    Denver, United States

  6. Milestone

    Website domain registered

    cleerly.com

Investors & Backers

15
Battery Ventures
Cigna Ventures
DigiTx Partners
Insight Partners
LRVHealth
New Leaf Venture Partners
Novartis Venture Fund
Peter Thiel
Piper Heartland Healthcare Capital
Presight Capital
Pura Vida Investments
Sands Capital Ventures
T. Rowe Price
THE CATALYTIC IMPACT FOUNDATION (CIF)
Vensana Capital

Funding History

3 Rounds
Series-B+ · Jan 24, 2025
Series-B+ · Dec 6, 2024
Series-B+ · Jul 25, 2022
Undisclosed Source

Founders & Leadership

8

Amit Relia

VP of Regulatory Affairs and Quality Assurance

Work email & phone locked Unlock →

Brandon Atkinson

Chief Operating Officer

Work email & phone locked Unlock →

James Min

Founder

Work email & phone locked Unlock →

James P Earls

Chief Medical Officer

Work email & phone locked Unlock →

Jim Hartman

Chief Revenue Officer

Work email & phone locked Unlock →

Kimberly McCombs

Chief Strategy Officer

Work email & phone locked Unlock →

Nick Nieslanik

Chief Technology Officer

Work email & phone locked Unlock →

Udo Hoffmann

Chief Medical, Scientific and AI Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts